ICAD INC. - COMMON STOCK

First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States

14 ديسمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

06 ديسمبر 2021 13:38:56 بحسب Nasdaq GlobeNewswire

iCAD Announces CEO Transition

06 ديسمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire

iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021

29 نوفمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference

11 نوفمبر 2021 16:05:01 بحسب Nasdaq GlobeNewswire

iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment

11 نوفمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for the Quarter Ended September 30, 2021

09 نوفمبر 2021 16:05:01 بحسب Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9

26 أكتوبر 2021 08:00:03 بحسب Nasdaq GlobeNewswire

iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)

07 أكتوبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D Mammography

29 سبتمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 Impact

09 سبتمبر 2021 14:46:04 بحسب Nasdaq GlobeNewswire

iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative Study

31 أغسطس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for the Quarter Ended June 30, 2021

05 أغسطس 2021 16:01:02 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the Guggenheim MedTech Disruptors Summit

02 أغسطس 2021 16:05:01 بحسب Nasdaq GlobeNewswire

iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5

22 يوليو 2021 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

14 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Signs Global Distribution Agreement with Sectra

08 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD to Participate in Upcoming Virtual Investor Conferences

17 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire

iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25

17 مايو 2021 08:00:02 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2021

28 أبريل 2021 16:01:00 بحسب Nasdaq GlobeNewswire